JD Health International Inc. (6618.HK)
6618.HK Stock Price Chart
Explore JD Health International Inc. interactive price chart. Choose custom timeframes to analyze 6618.HK price movements and trends.
6618.HK Company Profile
Discover essential business fundamentals and corporate details for JD Health International Inc. (6618.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
8 Dec 2020
Employees
3.56K
Website
https://ir.jdhealth.comCEO
Enlin Jin
Description
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
6618.HK Financial Timeline
Browse a chronological timeline of JD Health International Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Mar 2026
Earnings released on 13 Aug 2025
EPS came in at $0.89 falling short of the estimated $1.09 by -18.81%, while revenue for the quarter reached $38.55B , beating expectations by +4.09%.
Earnings released on 5 Mar 2025
EPS came in at $0.72 surpassing the estimated $0.67 by +8.06%, while revenue for the quarter reached $31.72B , beating expectations by +0.69%.
Earnings released on 15 Aug 2024
EPS came in at $0.70 falling short of the estimated $0.71 by -1.41%, while revenue for the quarter reached $30.44B , missing expectations by -3.28%.
Earnings released on 20 Mar 2024
EPS came in at $0.20 falling short of the estimated $0.48 by -58.07%, while revenue for the quarter reached $29.24B , missing expectations by -57.10%.
Earnings released on 17 Aug 2023
EPS came in at $0.53 surpassing the estimated $0.42 by +28.33%, while revenue for the quarter reached $29.32B , missing expectations by -2.31%.
Earnings released on 23 Mar 2023
EPS came in at $0.06 falling short of the estimated $0.35 by -84.04%, while revenue for the quarter reached $30.19B , missing expectations by -55.60%.
Earnings released on 30 Jun 2022
EPS came in at $0.08 falling short of the estimated $0.25 by -66.90%, while revenue for the quarter reached $23.68B , beating expectations by +4.38%.
Earnings released on 31 Dec 2021
EPS came in at -$0.24 falling short of the estimated $0.21 by -217.15%, while revenue for the quarter reached $20.87B , beating expectations by +13.89%.
Earnings released on 30 Jun 2021
EPS came in at -$0.18 falling short of the estimated $0.07 by -345.11%, while revenue for the quarter reached $16.37B , beating expectations by +9.67%.
Earnings released on 31 Dec 2020
EPS came in at -$6.22 falling short of the estimated -$0.06 by -10.39K%, while revenue for the quarter reached $12.59B , beating expectations by +8.54%.
6618.HK Stock Performance
Access detailed 6618.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.